Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Genetics and Metabolism|November 7, 2006
Therapy for Gaucher disease: don't stop thinking about tomorrowEllen Sidransky, Mary E LaMarca, Edward I Ginns
Molecular Genetics and Metabolism|September 5, 2002
Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotypeEduard Orvisky, Joseph K Park, Mary E LaMarca, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2004
DNA targeting of rhinal cortex D2 receptor protein reversibly blocks learning of cues that predict rewardZheng Liu, Barry J Richmond, Elisabeth A Murray, et al.
Molecular Genetics and Metabolism|October 11, 2011
Skin ultrastructural findings in type 2 Gaucher disease: diagnostic implicationsAegean Chan, Walter M Holleran, Tajh Ferguson, et al.
Clinical Chemistry|October 20, 2019
High-Throughput Mass Spectrometry Assay for Quantifying β-Amyloid 40 and 42 in Cerebrospinal FluidDarren M Weber, Diana Tran, Scott M Goldman, et al.
Molecular Genetics and Metabolism|January 7, 2014
Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunctionEdward I Ginns, Sally K-K Mak, Novie Ko, et al.
European Journal of Human Genetics : EJHG|January 17, 2013
Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypesPablo R Moya, Nicholas H Dodman, Kiara R Timpano, et al.
Biological Psychiatry|May 18, 2016
DNA Methylation Signatures of Early Childhood Malnutrition Associated With Impairments in Attention and CognitionCyril J Peter, Laura K Fischer, Marija Kundakovic, et al.
Molecular Genetics and Metabolism|November 28, 2017
Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and courseNahid Tayebi, Loukia Parisiadou, Bahafta Berhe, et al.
Pageof 2